A continually updated list of centrally authorised products (updated 2025-09-14)
Cancer medicines for children
Clinical trials analyses: ctrdata, a tool for leveraging register data
The post presents a readily-usable tool with a permissive licence for CTIS2, EUCTR, CTGOV2 and ISRCTN with examples addressing research questions (updated 2025-08-31)
Regulatory science, Drug development tools (DDTs)
A list of tools such as biomarkers, simulation approaches, new endpoints, novel methods, commented by regulatory agencies, updated daily
Information on medicines and assessments
Interactive webapp about centrally authorised medicines and their assessments (EPARs), updated daily
PIPs – Paediatric medicines investigations
A searchable webapp showing details of development plans (PIPs), updated daily
Cancer calculators
Incomplete list of calculators of risk, prognosis and outcome for a cancer given patient-specific information (updated 2024-12-02)
Addressing treatments for cancer patients
Videos, interviews, publications and presentations by Ralf Herold to promote progress for children and adults with cancer (updated 2024-11-30)
Adult cancer medicines: starting trials with children
Many are relevant to be studied in children with cancer (updated 2022-04-24)Development going beyond rare adult tumour
Examples of medicines with development for children triggered by melanoma in adults (updated 2021-12-30)
Mortality from childhood cancer decreasing
Data from the WHO indicate favourable trend continues in Europe (updated 2021-09-18)
Innovation coming to paediatric research
Clinical trials with children are evolving and improving (updated 2020-04-13)More data sources and application programming interface (API)
Distributed and diverse public information is combined by this web service and shared in APIs for deepening understanding and improving of medicine development and availability (updated 2020-09-12)